Vireo Growth (VREOF) Finished Goods (2020 - 2026)
Vireo Growth (VREOF) posted Finished Goods of $31.0 million for Q1 2026, up 58.16% sequentially from $19.6 million in Q4 2025, and up 385.11% YoY from $6.4 million in Q1 2025.
Vireo Growth (VREOF) Finished Goods (2020 - 2026) Analysis & Trends
Vireo Growth has reported Finished Goods for 7 years, with the latest figure at $31.0 million in Q1 2026.
- Quarterly Finished Goods rose 385.11% year-over-year to $31.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.0 million (up 385.11% YoY) and the FY2025 annual result came in at $19.6 million, up 230.34% from the prior year.
- Finished Goods advanced to $31.0 million in Q1 2026 per VREOF's latest filing, from $19.6 million in the prior quarter.
- Over five years, Finished Goods peaked at $31.0 million in Q1 2026 and troughed at $4.1 million in Q3 2022.
- A 5-year average of $9.3 million and a median of $5.8 million in 2024 frame the typical range for Finished Goods.
- The sharpest annual moves came in 2022 and 2026: Finished Goods retreated 15.13% in 2022, then jumped 385.11% in 2026.
- Over 5 years, Finished Goods stood at $5.5 million in 2022, then declined by 4.15% to $5.3 million in 2023, then rose by 12.41% to $5.9 million in 2024, then jumped by 230.34% to $19.6 million in 2025, then surged by 58.16% to $31.0 million in 2026.
- According to Business Quant data, Finished Goods over the past three periods registered $31.0 million, $19.6 million, and $18.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Vireo Growth | 487.39 Mn | 345.09 Mn | 95.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.00 Mn |
| Dec 31, 2025 | 19.60 Mn |
| Sep 30, 2025 | 18.32 Mn |
| Jun 30, 2025 | 18.64 Mn |
| Mar 31, 2025 | 6.39 Mn |
| Dec 31, 2024 | 5.93 Mn |
| Sep 30, 2024 | 5.81 Mn |
| Jun 30, 2024 | 5.91 Mn |
| Mar 31, 2024 | 5.32 Mn |
| Dec 31, 2023 | 5.28 Mn |
| Sep 30, 2023 | 5.48 Mn |
| Jun 30, 2023 | 5.13 Mn |
| Mar 31, 2023 | 5.94 Mn |
| Dec 31, 2022 | 5.51 Mn |
| Sep 30, 2022 | 4.10 Mn |
| Jun 30, 2022 | 4.82 Mn |
| Mar 31, 2022 | 4.66 Mn |
| Dec 31, 2021 | 4.58 Mn |
| Sep 30, 2021 | 4.83 Mn |
| Jun 30, 2021 | 4.53 Mn |